Maarten Slagter - Concepedia

Author

Maarten Slagter

The Netherlands Cancer Institute ORCID

Also Known As

M. Slagter, Maarten Slagter, Niels Halama

Publications

5.3K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Oncode Institute Nanostring Technologies (United States)Ghent University Hospital Cancer Genomics Centre

About

Maarten Slagter is an author at The Netherlands Cancer Institute specializing in immunology, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	2.9K
2	Immunology	4	4	2.9K
3	Cell Biology	1	1	1K
4	Cellular Therapies	1	1	1K
5	Molecular Biology	1	1	687

Maarten Slagter

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types Daniel J. McGrail, P.G. Pilié, N.U. Rashid, Annals of Oncology	2021	1K
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids Krijn K. Dijkstra, Chiara M. Cattaneo, Fleur Weeber, Cell Tumor-reactive T CellsCell TherapyCancer ImmunosurveillancePeripheral Blood LymphocytesT-regulatory Cell	2018	1K
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings, Nature Medicine Tumor ImmunologyBreast OncologyCancer ImmunosurveillancePd-1 BlockadeMedicine	2019	854
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators Riccardo Mezzadra, Chong Sun, Lucas T. Jae, Nature Protein FunctionSignal TransductionProtein ExpressionMolecular RegulationMolecular Biology	2017	687
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers Wouter Scheper, Sander Kelderman, Lorenzo F. Fanchi, Nature Medicine Cancer ImmunosurveillanceIntratumoral Tcr RepertoireMedicineImmunologyTumor Immunity	2018	556
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis Max D. Wellenstein, Seth B. Coffelt, Danique E. M. Duits, Nature InflammationBreast Cancer MetastasisBreast OncologyMedicineImmunology	2019	484
Distinct spatiotemporal dynamics of CD8+ T cell-derived cytokines in the tumor microenvironment Mirjam E. Hoekstra, Maarten Slagter, Jos Urbanus, Cancer Cell	2024	69
Adaptive phase II randomized trial of nivolumab after induction treatment in triple negative breast cancer (TONIC trial): Final response data stage I and first translational data. Marleen Kok, Leonie Voorwerk, Hugo M. Horlings, Journal of Clinical Oncology	2018	40
Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings, Nature Medicine	2019	27
Contact-Dependent Killing by Cytotoxic T Lymphocytes Is Insufficient for EL4 Tumor Regression <i>In Vivo</i> Richard J. Beck, Maarten Slagter, Joost B. Beltman Cancer Research	2019	24

Page 1